NEWSMAX: …In clinical trials involving patients at high risk of developing the disease, the Pitt vaccine was shown to boost the body’s natural immune defenses to target early signs of colon cancer and prevent its growth…
“This prophylactic colon cancer vaccine boosts the patient’s natural immune surveillance, which potentially could lead to the elimination of premalignant lesions before their progression to cancer,” said Olivera Finn, head of the Department of Immunology at Pitt’s School of Medicine and the vaccine’s developer, in a university press release.
“This might spare patients the risk and inconvenience of repeated invasive surveillance tests, such as colonoscopy, that currently are used to spot and remove precancerous polyps.”… (more)
